Laniohan, Francisco Y.

HRN: 15-66-65  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2026
CEFTRIAXONE 1G (VIAL)
01/08/2026
01/15/2026
IV
2G
OD
PLEURAL EFUSION RIGHT PROB SEC TO PARAPNEUMONIC PROCESS VS PTB
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines